Background: The accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography
(FDG-PET) for diagnosing nodal status in patients with lung cancer was initially reported as …

The use of PET/CT imaging in the work-up and management of patients with lung cancer
has greatly increased in recent decades. The ability to combine functional and anatomical …

OBJECTIVES: Pretreatment staging of patients with non–small cell lung cancer is critically
important in determining an appropriate treatment plan. As positron emission tomography …

The integral role of positron-emission tomography (PET) using the glucose analog tracer
fluorine-18 fluorodeoxyglucose (FDG) in the staging of non-small cell lung cancer (NSCLC) …

Abstract Introduction 2-[18 F] Fluoro-d-deoxyglucose (FDG) positron emission tomography
(PET) is a relevant diagnostic procedure for staging lung cancer. However, accurate …

Purpose Positron emission tomography-computed tomography (PET-CT) is a resource-
demanding imaging modality with increasing popularity in the workup of patients with …

Over the past years, positron emission tomography (PET) with fluoro-2-deoxy-d-glucose
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …

Background Positron emission tomography (PET) scanningis used increasingly to detect
and stage lung cancer, but the testperformance characteristics and relationship of PET to …

Correctly staging lung cancer is extremely important because treatment options and
prognosis differ significantly by stage. In this review, the performance characteristics of …

To determine the sensitivity, specificity, and accuracy of staging mediastinal nodal disease
in potentially resectable lung cancer using fluorodeoxyglucose–positron emission …